Navigation Links
Researchers Find More Genes Linked to Lung Cancer
Date:10/22/2008

Discovery could lead to new targeted, individualized treatments, experts say

WEDNESDAY, Oct. 22 (HealthDay News) -- Researchers have identified 26 genes associated with the most common type of lung cancer, adenocarcinoma -- more than doubling the number of genes known to play a role in the deadly disease.

The discovery could help in developing individualized ways of diagnosing and treating lung cancer, the top cancer killer, the researchers said.

"Although similar, smaller cancer gene sequencing projects have been reported, our study is the largest to date and provides the statistical power to detect significantly mutated genes," study co-author Richard Wilson, director of Washington University's Genome Sequencing Center in St. Louis, said during a Tuesday teleconference.

The research, known as the Tumor Sequencing Project, has important implications for the understanding, diagnosis and treatment of lung cancer, Wilson said. "But we consider it just a beginning. Over the next few years, we expect to extend this study both in terms of the number of individual cases that we study and the extent of the cancer genome we can explore," he said.

Before the new research, 10 genes linked to adenocarcinoma had been identified, including six of the 26 reported in this study. The findings were published in the Oct. 23 issue of Nature.

For the study, researchers looked for genetic mutations in lung cancer cells. These changes occur in the tumor and are not inherited or found elsewhere in the body, Dr. Matthew Meyerson, from the Broad Institute of MIT and Harvard and an associate professor at the Dana-Farber Cancer Institute in Boston, said during the teleconference.

"These mutations are important, because mutated genes can be targets for anti-cancer therapy," Meyerson said.

The researchers determined the DNA sequence of 623 genes in 188 lung adenocarcinomas. Then they compared the DNA sequence of these genes with the same genes in normal tissue from the same patients.

"By doing this, we identified 26 genes that are frequently mutated in lung adenocarcinoma," Meyerson said. "Most of these gene mutations are newly discovered."

Some of these genes have been implicated in other cancers, such as colon cancer, leukemia and lymphoma. "These genes could soon be new targets for lung cancer treatments," Meyerson said.

The researchers also looked at genetic mutations found among different adenocarcinoma patients. Most cases of lung cancer (90 percent) occur in smokers. Among smokers, there were many more gene mutations than those found in the lung cancer tumors of nonsmokers.

Tumors for smokers had as many as 49 mutations, while none of the nonsmokers had more than five mutations, the researchers reported.

"Our study could achieve a real impact on the care of lung cancer patients," Meyerson said. "It is important to study the role of the mutated genes in the growth and survival of lung cancer cells, which will help us work toward new treatments."

Dr. Norman H. Edelman, chief medical officer of the American Lung Association, called the new research another positive step in understanding cancer and could lead to new therapies.

"The methods of this study are powerful, and the sample is large, thus it is a good study. We can expect more like this," Edelman said. "The genetic basis of cancer is very complex, and this represents another piece of the puzzle. Whether or not finding newly implicated genes will lead to new therapies, as the authors suggest, is, of course, something to be hoped and waited for."

Lung cancer is the leading cause of cancer deaths in the United States and around the world. More than 1 million people worldwide die of lung cancer each year, including more than 160,000 people in the United States. Lung adenocarcinoma, the most frequently diagnosed form of lung cancer, has an average five-year survival rate of just 15 percent, the researchers said.

More information

For more on lung cancer, visit the U.S. National Cancer Institute.



SOURCES: Norman H. Edelman, M.D., professor, Preventive Medicine, Internal Medicine, Physiology and Biophysics, Stony Brook University, N.Y., and chief medical officer, American Lung Association, New York City; Oct. 22, 2008, teleconference with Richard Wilson, Ph.D., professor of genetics, and director, Genome Sequencing Center, Washington University, St. Louis; Matthew Meyerson, M.D., Ph.D., Broad Institute of MIT and Harvard, associate professor, Dana-Farber Cancer Institute and Harvard Medical School, Boston; Oct. 23, 2008, Nature


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
2. Georgetown University Med Center reproductive health researchers tackle public health concerns
3. Stem-cell sentry sounds the alarm to maintain balance between cancer and aging, U-M researchers find
4. Steroids aid recovery from pneumonia, UT Southwestern researchers say
5. Researchers Create Embryonic-Like Stem Cells From Human Testes
6. UT researchers to study massive transfusion at major trauma centers
7. Duke researchers show reading can help obese kids lose weight
8. Researchers use nanoparticles to deliver treatment for brain, spinal cord injuries
9. Researchers create first model for retina receptors
10. Researchers Report Stem Cell Advance
11. ALS Patients and Researchers Unite in Boston for 4th Annual Leadership Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
Breaking Medicine Technology: